Stefan Constantinescu, MD, PhD, to Member of the Brussels Branch.
Stefan Constantinescu, MD, PhD
We are pleased to announce that the LICR Board of Directors has approved the appointment of Stefan Constantinescu, MD, PhD, to Member of the Brussels Branch. Since joining the Branch in 2000, Dr. Constantinescu has built an outstanding team with an international reputation on signal transduction and the pathogenesis of myeloproliferative disorders. He was instrumental in discovering the activating JAK-STAT pathway mutations in myeloproliferative disorders and continues to demonstrate an outstanding level of innovation and cutting edge research in this area.
Dr. Constantinescu is recognized as a brilliant and imaginative researcher and one of the world leaders in the molecular analysis of transmembrane receptor activation and signal transduction. His work continues to advance the understanding of the mechanisms of cytokine receptor activation and function, a major unsolved problem in cell biology, hematology and immunology. He has been widely praised for his scientific maturity and dedication to education and his extraordinary insights into areas as diverse as membrane biochemistry and oncogenesis. Dr. Constantinescu became an Associate Professor at the Université Catholique de Louvain and a tenured Investigator at the Belgian National Fund for Scientific Research (FNRS) in 2003. He was awarded the de Hovre Prize in immunology that same year and was the recipient of a grant from the Mandat d’Impulsion of the FNRS for 2004-2007. He received an MD cum laude and a PhD in Virology at the University of Medicine and Pharmacy, Bucharest and an Equivalence of PhD in Biomedical Sciences at the Université catholique de Louvain.